Moderna | MRNA - Pre Tax Profit



Moderna reported $-818000000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amgen USD 1.57B 405M Jun/2025
Arrowhead Research USD -179089000 548.7M Jun/2025
Biogen USD 744M 432.8M Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Celltrion KRW 195.49B 78.5B Mar/2025
Cspc Pharmaceutical CNY 833.21M 111.17M Dec/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Divis Laboratories Ltd 7.33B 1.31B Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Kangmei Pharma -5720000 15.38M Sep/2024
Knight Therapeutics CAD -7144000 19.01M Mar/2024
Laboratorios Farma 26.78M 94.77M Jun/2025
Moderna USD -818000000 146M Jun/2025
Organigram Holdings CAD -16200000 6.76M Jun/2025
Pharma Mar EUR 23.35M 27.26M Jun/2025
Qiagen NV USD 126.82M 7.27M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Sartorius EUR 70.9M 28.6M Jun/2025
Tilray USD -83239000 49.47M Nov/2024
Ultragenyx Pharmaceutical USD -114004000 35.77M Jun/2025
United Therapeutics USD 408.4M 15.1M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025
Zz Pientze Pharmaceu 523.11M 659.54M Jun/2025